Why the study?
Although Chinese chest pain centers have expanded and matured, patient wait times for pre-hospital care remain long.
Does remote real-time dynamic 12-lead ECG monitoring reduce time to treatment and improve clinical outcomes in STEMI patients undergoing primary PCI?
Does remote real-time dynamic 12-lead ECG monitoring reduce time to treatment and improve clinical outcomes in STEMI patients undergoing primary PCI?
The use of remote real-time dynamic 12-lead ECG monitoring in chest pain centers significantly reduces reperfusion times and 30-day mortality in patients with STEMI.
Answers are grounded in this paper and cite their sources.
Remote ECG monitoring may shorten STEMI prehospital delays; hypothesis-generating and requires prospective validation before practice change.
BACKGROUND: Chinese chest pain centers (CPCs) have been expanding and maturing for the past decade, but patient wait times for pre-hospital care remain long. OBJECTIVE: To demonstrate that the remote electrocardiogram (ECG) monitoring system can ensure more efficient treatment for patients with ST-elevation myocardial infarction (STEMI) in CPCs, we compared patients with high-risk chest pain who used remote ECG monitoring systems to those who used conventional ECGs in retrospective cohort study. METHODS: Based on the inclusion and exclusion criteria, 290 patients who visited our CPC between June 2019 and March 2022 with acute chest pain and a diagnosis of STEMI as well as patients who had undergone an emergency primary percutaneous coronary intervention were selected. Among them, 73 patients with STEMI had employed remote real-time dynamic 12-lead ECG monitoring devices, while 217 patients with STEMI (i.e., the controls) had used conventional ECG monitoring. The effectiveness of treatment procedures for the two groups was investigated. As statistical measures, the symptom onset-to-wire times, first medical contact (FMC)-to-wire times, door-to-wire times, major adverse cardiac events in hospital, and the troponin T levels were analyzed. RESULTS: Compared with the control group, the patients with remote real-time dynamic 12-lead ECG monitoring devices showed shorter times for both symptom onset-to-wire (234.8 ± 95.8 min vs. 317.6 ± 129.6 min, P= 0.0321) and from symptom onset-to-FMC (170.5 ± 86.3 min vs. 245.3 ± 115.6 min, P= 0.0287); this group also had a lower 30-day mortality rate (2.73% vs. 4.14%, P= 0.003). The differences between the two groups were statistically significant (P< 0.05). CONCLUSION: With remote real-time dynamic 12-lead ECG monitoring equipment, myocardial ischemia can be treated more quickly, leading to fewer possible cardiac events and a better prognosis.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: